RUA Life Sciences plc (LON:RUA – Get Free Report)’s share price reached a new 52-week high on Tuesday. The company traded as high as GBX 31 and last traded at GBX 29.15, with a volume of 258,327 shares changing hands. The stock had previously closed at GBX 30.
RUA Life Sciences Price Performance
The stock has a market capitalization of £18.09 million, a price-to-earnings ratio of -2.61 and a beta of 0.99. The business’s fifty day moving average price is GBX 27.60 and its 200-day moving average price is GBX 22.40. The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32.
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
See Also
- Five stocks we like better than RUA Life Sciences
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
